Thomas B. Smith - 10 Feb 2023 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role: EVP and Chief Medical Officer
Signature: /s/ Colleen Tupper as Attorney-In-Fact For Thomas B. Smith, MD
Issuer symbol: COLL
Transactions as of: 10 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 14 Feb 2023, 16:19:23 UTC
Previous filing: 01 Apr 2022
Next filing: 14 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COLL	Common Stock	Award	$0	+31,185		$0.000000	31,185	10 Feb 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Content

Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.